Development of hollow ferrogadolinium nanonetworks for dual-modal MRI guided cancer chemotherapyElectronic supplementary information (ESI) available. See DOI: 10.1039/c8ra09102a

The development of hollow ferrogadolinium nanonetworks has not been reported for nanomedicine application until now. In this study, we developed a hollow and porous ferrogadolinium nanonetwork structure using the one-pot solvothermal method. This nanoparticle could be simultaneously used as a T 1 an...

Full description

Saved in:
Bibliographic Details
Main Authors: Tang, Ting, Sun, Xiao, Xu, Xuedong, Bian, Yifeng, Ma, Xiaojie, Chen, Ning
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The development of hollow ferrogadolinium nanonetworks has not been reported for nanomedicine application until now. In this study, we developed a hollow and porous ferrogadolinium nanonetwork structure using the one-pot solvothermal method. This nanoparticle could be simultaneously used as a T 1 and T 2 dual-modal magnetic resonance imaging (MRI) contrast agent. In addition, the hollow lumen and abundant pores of the nanonetworks maximized the loading capacity and conferred the nanoplatforms for suitable anticancer drug loading capacity. Using these nanonetworks, MRI and anticancer experiments were conducted in vitro and satisfactory dual-modal MRI and cancer chemotherapy results were obtained. Therefore, the nanonetworks with dual-modal MRI and drug loading abilities effectively complement the ferrogadolinium composites' library and hold great promise in nanomedicine for simultaneous cancer diagnosis and chemotherapy. This multifunctional nanomaterial with a nanonetwork architecture can be used for dual-modal MRI guided cancer chemotherapy.
ISSN:2046-2069
DOI:10.1039/c8ra09102a